100 related articles for article (PubMed ID: 488301)
1. Substance P in medullary carcinoma of the thyroid.
Skrabanek P; Cannon D; Dempsey J; Kirrane J; Neligan M; Powell D
Experientia; 1979 Sep; 35(9):1259-60. PubMed ID: 488301
[TBL] [Abstract][Full Text] [Related]
2. Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour.
Conlon JM; Schäfer G; Schmidt WE; Lazarus LH; Becker HD; Creutzfeldt W
Regul Pept; 1985 Jun; 11(2):117-32. PubMed ID: 2412263
[TBL] [Abstract][Full Text] [Related]
3. Substance P in the argentaffin carcinoid of the caecum: biochemical and biological characterization.
Ratzenhofer M; Gamse R; Höfler H; Auböck L; Popper H; Pohl P; Lembeck F
Virchows Arch A Pathol Anat Histol; 1981; 392(1):21-31. PubMed ID: 6169190
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-releasing peptide-like immunoreactivity in medullary thyroid carcinoma.
Ghatei MA; Springall DR; Nicholl CG; Polak JM; Bloom SR
Am J Clin Pathol; 1985 Nov; 84(5):581-6. PubMed ID: 4061381
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay.
Deftos LJ; Linnoila RI; Carney DN; Burton DW; Leong SS; O'Connor DT; Murray SS; Gazdar AF
Cancer; 1988 Jul; 62(1):92-7. PubMed ID: 2838150
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of substance P-like immunoreactivity in human thyroid and medullary carcinoma of the thyroid.
Kakudo K; Vacca LL
J Submicrosc Cytol; 1983 Apr; 15(2):563-8. PubMed ID: 6687904
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
8. Medullary carcinoma of the thyroid with carcinoid-like features.
Harach HR; Bergholm U
J Clin Pathol; 1993 Feb; 46(2):113-7. PubMed ID: 8459030
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of multiple neurohormonal polypeptides in a case of pure testicular carcinoid.
Ordóñez NG; Ayala AG; Sneige N; Mackay B
Am J Clin Pathol; 1982 Dec; 78(6):860-4. PubMed ID: 6183972
[TBL] [Abstract][Full Text] [Related]
10. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors.
Emson PC; Gilbert RF; Martensson H; Nobin A
Cancer; 1984 Aug; 54(4):715-8. PubMed ID: 6204735
[TBL] [Abstract][Full Text] [Related]
11. alpha-Neoendorphin-like immunoreactivity in medullary carcinoma of the thyroid.
Ohashi M; Yanase T; Fujio N; Ibayashi H; Kinjo M; Matsuo H
Cancer; 1987 Jan; 59(2):277-80. PubMed ID: 3802014
[TBL] [Abstract][Full Text] [Related]
12. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
[No Abstract] [Full Text] [Related]
13. Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma.
Matsubayashi S; Yanaihara C; Ohkubo M; Fukata S; Hayashi Y; Tamai H; Nakagawa T; Miyauchi A; Kuma K; Abe K
Cancer; 1984 Jun; 53(11):2472-7. PubMed ID: 6370416
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.
Conlon JM; Grimelius L; Thim L
Biochem J; 1988 Nov; 256(1):245-50. PubMed ID: 3265620
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
16. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
17. Metastatic medullary thyroid carcinoma or calcitonin-secreting carcinoid tumor of lung? A diagnostic dilemma in a patient with lung mass and thyroid nodule.
Vahidi S; Stewart J; Amin K; Racila E; Li F
Diagn Cytopathol; 2018 Apr; 46(4):345-348. PubMed ID: 29124912
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma.
Shibasaki T; Deftos L; Guillemin R
Biochem Biophys Res Commun; 1979 Oct; 90(4):1266-73. PubMed ID: 229834
[No Abstract] [Full Text] [Related]
19. Thyroid metastases from typical carcinoid of the lung differentiating between medullary thyroid carcinoma and neuroendocrine tumor metastasis to the thyroid.
La Rosa S; Imperatori A; Giovanella L; Garancini S; Capella C
Thyroid; 2009 May; 19(5):521-6. PubMed ID: 19415998
[TBL] [Abstract][Full Text] [Related]
20. Substance P in the central nervous system.
Helme RD; White DW
Clin Exp Neurol; 1981; 18():156-60. PubMed ID: 6188563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
